文献速递男科与性医学

前列腺素E1海绵体注射对血管性勃起功能障碍勃起时长与硬度的剂量依赖性研究

Effect of Intracavernosal Injection of Prostaglandin E1 on Duration and Rigidity of Erection in Patients With Vasculogenic Erectile Dysfunction: Is It Dose Dependent?
PubMed 文献 · Urology · 2020-10-02

海绵体注射前列腺素E1从5μg起始,按需递增至10μg和20μg,评估勃起硬度及持续时间。结果显示不同血管性ED类型达到最佳反应所需剂量不同,混合性ED所需剂量最高。

要点

  • 前列腺素E1递增剂量可改善各型血管性ED的勃起硬度与持续时间。
  • 心理性ED组88%在5μg剂量即达最佳反应,动脉性组仅5.3%。
  • 混合性动脉与静脉闭塞性ED达到最佳反应所需PGE1剂量最高。

核心结论

  • 递增剂量前列腺素E1海绵体注射可改善不同血管性ED患者的勃起硬度与持续时间。
  • 混合性动脉性与静脉闭塞性ED患者达到最佳反应所需PGE1剂量最高。

研究设计与样本

  • 海绵体注射PGE1从5μg起始,按需递增至10μg和20μg,采用阴茎多普勒超声及勃起硬度评分评估。

主要发现

  • A、B、C、D组平均PSV分别为24.38±3.3、37.74±8.28、22.24±3.85、47.76±6.27。
  • 心理性ED组88%在5μg剂量达最佳反应,动脉性组5.3%、静脉闭塞性组21.7%、混合性组0%在5μg达最佳反应(每组P<.05)。
  • 其余患者需10μg或20μg达到最佳反应,混合性ED组所需PGE1剂量最高(P<.05)。

临床怎么用

  • 对血管性ED患者行海绵体注射PGE1时,应根据ED类型调整剂量,混合性ED可能需要更高剂量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess if the effect of intracavernosal injection of prostaglandin E1 (PGE1) on duration and rigidity of erection is dose dependent in patients with different types of vasculogenic erectile dysfunction (ED)? METHODS: A hundred patients with ED were assigned into 4 groups (n = 25/each); group (A) patients with arteriogenic ED, group (B) patients with veno-occlusive ED, group (C) patients with mixed (arteriogenic and veno-occlusive) ED, and group (D) patients who have only psychogenic ED (control). After intracavernosal injection of PGE1, patients were assessed using penile Doppler ultrasonography and erection hardness score together with calculation of erection duration. The starting dose of PGE1 was 5 μg which was increased to 10 µg and 20 µg as a maximal dose when needed. RESULTS: The mean PSV of patients in groups A, B, C, and D were 24.38 ± 3.3, 37.74 ± 8.28, 22.24 ± 3.85, and 47.76 ± 6.27, respectively. In group D, 88% have achieved the best response at dose of 5 µg while 5.3%, 21.7%, and 0% have achieved the best response at dose of 5 µg in groups A, B, and C, respectively (P < .05 for each). The rest of patients have required either 10 or 20µg to achieve the best response. Patients in group C have required the highest dose of PGE1 to achieve the best response (P < .05). CONCLUSION: Intracavernosal injection of PGE1 in escalating doses have improved the rigidity and duration of erection in patients with different types of vasculogenic ED. Patients with mixed arteriogenic and veno-occlusive ED have required the highest dose of PGE1 to achieve the best response.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Bassiem MA, Ismail IY, Salem TA, et al. Effect of Intracavernosal Injection of Prostaglandin E1 on Duration and Rigidity of Erection in Patients With Vasculogenic Erectile Dysfunction: Is It Dose Dependent? Urology. 2020. PMID: 33017615. doi:10.1016/j.urology.2020.09.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。